We are live on ! Find out more
WST icon

West Pharmaceutical
WST

302 hedge funds and large institutions have $6.72B invested in West Pharmaceutical in 2017 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 118 increasing their positions, 96 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,006% more call options, than puts

Call options by funds: $1.01M | Put options by funds: $48K

23% more repeat investments, than reductions

Existing positions increased: 118 | Existing positions reduced: 96

6% more capital invested

Capital invested by funds: $6.36B → $6.72B (+$352M)

2.76% more ownership

Funds ownership: 91.55% → 94.31% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

10% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 41

2% less funds holding

Funds holding: 309 → 302 (-7)

Holders
302
Holders Change
-7
Holders Change %
-2.27%
% of All Funds
7.53%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
37
Increased
118
Reduced
96
Closed
41
Calls
$1.01M
Puts
$48K
Net Calls
+$963K
Net Calls Change
+$170K

Top Buyers

1
William Blair Investment Management
William Blair Investment Management
Illinois
+$80.4M
2
Artisan Partners
Artisan Partners
Wisconsin
+$76.2M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$48.1M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$47.1M
5
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$33.7M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$65.5M
2
BlackRock
BlackRock
New York
-$29.8M
3
O
OppenheimerFunds
New York
-$28.7M
4
CWAM
Columbia Wanger Asset Management
Illinois
-$21.4M
5
Morgan Stanley
Morgan Stanley
New York
-$19.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
OC
151
Oppenheimer & Co
New York
$1.6M -$300K -3,311 -17%
BAM
152
Baring Asset Management
United Kingdom
$1.56M +$30.3K +335 +2%
SG Americas Securities
153
SG Americas Securities
New York
$1.47M -$1.03M -11,392 -43%
CSS
154
Cubist Systematic Strategies
Connecticut
$1.45M +$982K +10,857 +260%
State of Wisconsin Investment Board
155
State of Wisconsin Investment Board
Wisconsin
$1.44M +$28.1K +311 +2%
PSUF
156
People's United Financial
Connecticut
$1.42M -$32.1K -355 -2%
ZB
157
Zions Bancorporation
Utah
$1.41M +$269K +2,968 +25%
AB
158
Amalgamated Bank
New York
$1.41M -$28K -309 -2%
SMDAM
159
Sumitomo Mitsui DS Asset Management
Japan
$1.38M +$1.29M +14,310 New
CB
160
Commerce Bank
Missouri
$1.37M -$134K -1,483 -9%
CONA
161
Capital One National Association
New York
$1.32M -$22.3K -246 -2%
URS
162
Utah Retirement Systems
Utah
$1.29M – – –
AP
163
AHL Partners
United Kingdom
$1.27M -$1M -11,057 -46%
Bessemer Group
164
Bessemer Group
New Jersey
$1.2M +$52.3K +578 +5%
LPL Financial
165
LPL Financial
California
$1.2M +$492K +5,442 +79%
HIM
166
Hillsdale Investment Management
Ontario, Canada
$1.16M – – –
Natixis Advisors
167
Natixis Advisors
Massachusetts
$1.14M +$131K +1,443 +14%
CT
168
Cambridge Trust
Massachusetts
$1.12M -$80.3K -887 -7%
COPPSERS
169
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.04M +$5.43K +60 +0.6%
Pacer Advisors
170
Pacer Advisors
Pennsylvania
$1.02M +$122K +1,348 +15%
CGH
171
Crossmark Global Holdings
Texas
$1.01M +$948K +10,480 New
PA
172
Profund Advisors
Maryland
$981K +$93.2K +1,030 +11%
KPCM
173
Kings Point Capital Management
New York
$963K -$296K -3,270 -25%
GHCM
174
Glen Harbor Capital Management
California
$962K +$126K +1,394 +16%
PNC Financial Services Group
175
PNC Financial Services Group
Pennsylvania
$961K +$352K +3,890 +64%
5 6
7
8 9

WST Hedge Fund Activity: Q3 2017 in Review

302 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2017, worth a combined $6.72B — up 5.5% from $6.36B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of WST and 37 opened new positions — a net loss of 4 holders — while 96 trimmed existing stakes and 118 added.

The largest buyer was William Blair Investment Management, opening a new position worth an estimated $80.4M. The largest seller was Millennium Management, cutting an estimated $65.5M.

  • 302 institutional investors held West Pharmaceutical (WST) as of Q3 2017, down from 309 in Q2 2017.
  • Funds reported $6.72B of West Pharmaceutical stock for Q3 2017, up 5.5% quarter-over-quarter.
  • 37 funds opened new West Pharmaceutical positions in Q3 2017 and 41 closed out, a net change of -4 holders.
  • The largest West Pharmaceutical buyer in Q3 2017 was William Blair Investment Management, an estimated $80.4M added.
  • The largest West Pharmaceutical seller in Q3 2017 was Millennium Management, an estimated $65.5M sold.

Based on aggregated 13F filings for Q3 2017.